IP Library Patent Application 18400894
Patent Application
App. No. 18/400,894

MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/400,894
Abstract

The present disclosure provides modified antibodies which contain an antibody or antibody fragment (AB) modified with a masking moiety (MM). Such modified antibodies can be further coupled to a cleavable moiety (CM), resulting in activatable antibodies (AAs), wherein the CM is capable of being cleaved, reduced, photolysed, or otherwise modified. AAs can exhibit an activatable conformation such that the AB is more accessible to a target after, for example, removal of the MM by cleavage, reduction, or photolysis of the CM in the presence of an agent capable of cleaving, reducing, or photolysing the CM. The disclosure further provides methods of making and using such modified antibodies and activatable antibodies.

Claims (11)

1 . A cleavable polypeptide comprising a cleavable moiety (CM) comprising the amino acid sequence PLTGRSGG (SEQ ID NO: 274) and an antibody or antigen binding fragment thereof (AB) that binds a target.

2 . The cleavable polypeptide of claim 1 , wherein the antigen binding fragment thereof is selected from the group consisting of a Fab fragment, a F(ab′)2 fragment, a scFv, a scAb, a dAb, a single domain heavy chain antibody, and a single domain light chain antibody.

3 . The cleavable polypeptide of claim 1 , wherein the CM is a substrate for a protease that is co-localized in a tissue with the target.

4 . The cleavable polypeptide of claim 1 , wherein the AB is linked to the CM.

5 . The cleavable polypeptide of claim 1 , wherein the AB is linked to the CM via a linking peptide.

6 . A nucleic acid molecule encoding the cleavable polypeptide of claim 1 .

7 . A vector comprising the nucleic acid molecule of claim 6 .

8 . A method of producing a cleavable moiety (CM) containing polypeptide by culturing a cell under conditions that lead to expression of the polypeptide, wherein the cell comprises the vector of claim 7 .

9 . A method of manufacturing a cleavable moiety (CM) containing polypeptide, the method comprising:

(a) culturing a cell comprising a nucleic acid construct that encodes the cleavable polypeptide of claim 1 to express the cleavable polypeptide, and

(b) recovering the cleavable polypeptide.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2023
From: STAGLIANO, NANCY E.; WEST, JAMES WILLIAM; KAMATH, KATHRYN; BESSETTE, PAUL HENRY; GLUCK, FRED; SAGERT, JASON; DAUGHERTY, PATRICK
To: CYTOMX THERAPEUTICS, INC.
Reel/Frame 065984/0516 →